Theriva Biologics, Inc. (TOVX)
0.226
0.00 (0.00%)
USD |
NYAM |
Dec 11, 11:55
Theriva Biologics Cash from Investing (Quarterly): -0.019M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
| Oragenics, Inc. | 0.00 |
| NanoViricides, Inc. | -0.0843M |
| Actinium Pharmaceuticals, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.319M |
| Cash from Financing (Quarterly) | -0.148M |
| Free Cash Flow | -18.51M |
| Free Cash Flow Per Share (Quarterly) | -0.4483 |
| Free Cash Flow to Equity (Quarterly) | -4.209M |
| Free Cash Flow to Firm (Quarterly) | -4.338M |
| Free Cash Flow Yield | -1.49K% |